| Literature DB >> 33484882 |
Zhidong Teng1, Shiqi Sun1, Xin Luo1, Zhihui Zhang1, Hoseong Seo2, Xiaoyu Xu3, Jie Huang3, Hu Dong1, Suyu Mu1, Ping Du1, Zhijun Zhang4, Huichen Guo5.
Abstract
Virus-like particle (VLP) vaccines have become one of the dominant vaccine candidates for foot-and-mouth disease (FMD). To further enhance the immunogenicity of VLP vaccines, gold nanocages (AuNCs) were selected as an adjuvant for the vaccine. Our experiments demonstrated that AuNCs had little biotoxicity in vivo and in vitro and improved the uptake of VLP in BHK-21 and RAW264.7 cell lines. The VLP-AuNCs activated DCs mainly through toll-like receptor 4 (TLR4) and promoted the secretion of IL-6, IL-1β, and TNF-α. The conjugation of VLP and AuNCs triggered a strong immune response against FMD virus (FMDV) in mice and guinea pigs. The VLP-AuNCs significantly enhanced the proliferation of CD8+ T cells (P < 0.05) and the secretion of cellular immune-related cytokines (IFN-γ, P < 0.05; IL-12p70, P < 0.01) compared with VLP. The present study demonstrated that AuNCs, as a great potential adjuvant for FMDV VLP vaccines, significantly enhance the immune response.Entities:
Keywords: Adjuvant; Foot-and-mouth disease; Gold nanocages; Specific immune response; Virus-like particles
Mesh:
Substances:
Year: 2021 PMID: 33484882 DOI: 10.1016/j.nano.2021.102358
Source DB: PubMed Journal: Nanomedicine ISSN: 1549-9634 Impact factor: 5.307